Alphabet Inc (GOOGL) Investment Portfolio: Top 5 Companies

4. Lyell Immunopharma, Inc. (NASDAQ:LYEL)

Stake Value as of November 15: $38,241,000

Lyell Immunopharma, Inc. (NASDAQ:LYEL) is a California-based T cell reprogramming company that develops T cell therapies for patients with solid tumors. Lyell had raised $834 million across just three rounds since it was founded in 2018, and the company had a $425 million IPO. Alphabet’s GV was one of the primary investors in Lyell Immunopharma, Inc. (NASDAQ:LYEL). As of November 15, GV had a $38.2 million stake in the company. 

Follow Lyell Immunopharma Inc.